Hyperion Asset Management Ltd Buys 48,015 Shares of Intuitive Surgical, Inc. $ISRG

Hyperion Asset Management Ltd lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 28.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 218,646 shares of the medical equipment provider’s stock after purchasing an additional 48,015 shares during the quarter. Intuitive Surgical accounts for about 2.7% of Hyperion Asset Management Ltd’s holdings, making the stock its 13th largest position. Hyperion Asset Management Ltd’s holdings in Intuitive Surgical were worth $97,785,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Fayez Sarofim & Co lifted its holdings in Intuitive Surgical by 5.4% during the 3rd quarter. Fayez Sarofim & Co now owns 1,169,350 shares of the medical equipment provider’s stock worth $528,207,000 after purchasing an additional 60,210 shares in the last quarter. Focus Partners Wealth grew its holdings in Intuitive Surgical by 4.9% during the 3rd quarter. Focus Partners Wealth now owns 86,503 shares of the medical equipment provider’s stock valued at $38,686,000 after buying an additional 4,036 shares in the last quarter. Delta Global Management LP bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $2,568,000. Elevation Point Wealth Partners LLC increased its position in shares of Intuitive Surgical by 12.7% during the third quarter. Elevation Point Wealth Partners LLC now owns 2,018 shares of the medical equipment provider’s stock valued at $903,000 after buying an additional 227 shares during the period. Finally, Brevan Howard Capital Management LP lifted its holdings in shares of Intuitive Surgical by 895.3% in the third quarter. Brevan Howard Capital Management LP now owns 10,988 shares of the medical equipment provider’s stock worth $4,914,000 after buying an additional 9,884 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Insider Transactions at Intuitive Surgical

In related news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 421 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. This represents a 50.72% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 32,943 shares of company stock worth $17,279,568. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 1.5%

ISRG stock opened at $472.16 on Monday. The company’s 50 day moving average is $513.26 and its 200 day moving average is $512.96. The stock has a market cap of $167.68 billion, a price-to-earnings ratio of 59.84, a price-to-earnings-growth ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period last year, the firm posted $2.21 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ISRG. Royal Bank Of Canada raised their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. UBS Group set a $570.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Tuesday, February 24th. Evercore cut their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday, January 23rd. Finally, Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.